Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. radiology products
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Radiology Products Articles & Analysis

21 news found

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

Bayer driving innovation in radiology with new research across the portfolio presented at ECR

One of Bayer’s featured presentations focuses on the potential value of a learning algorithm in liver imaging, a key diagnostic area for Bayer’s radiology team. The presence of AI in radiology has grown quickly with over 200 AI applications having received a CE mark for the European market so far. ...

ByBayer AG


Bayer completes acquisition of Blackford Analysis Ltd.

Bayer completes acquisition of Blackford Analysis Ltd.

” “Blackford has built a strong reputation in the AI platform segment for radiology, with a wide portfolio of 3rd party products and a strong deployed base of hospitals, radiology groups and imaging centers,” said Ben Panter, Chief Executive Officer of Blackford. ...

ByBayer AG


Ultravist by Bayer now approved for contrast-enhanced mammography in EU

Ultravist by Bayer now approved for contrast-enhanced mammography in EU

The approval expands Bayer’s radiology portfolio, which includes contrast media, injectors as well as digital and artificial intelligence (AI) enabled solutions, supporting radiologists across a broad range of diseases including breast cancer. ...

ByBayer AG


Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

Bayer acquires Blackford Analysis Ltd. bolstering the company’s position in digital medical imaging

“Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceutical Division. ...

ByBayer AG


Ready to go mobile

Ready to go mobile

The Arktis Radiation Detectors MODES kit is designed to detect and identify radiological threats. The system can work either deployed in vehicles or as a stand-alone static monitor. The internal processing unit manages the real-time ambient spectrum. Also, our FPG drone technology can be integrated ...

ByArktis Radiation Detectors Ltd.


Subtle Medical Announces Partnership Expansion With Incepto

Subtle Medical Announces Partnership Expansion With Incepto

This expansion will provide their existing customer base with quick access to our AI solutions without the long implementation process or IT hurdles,” says Subtle Medical’s Chief Product Officer, Ajit Shankaranarayanan. “Today SubtleMR and SubtlePET AI based software products are installed at hundreds of facilities throughout the world making ...

BySubtle Medical, Inc.


Women’s Health and AI, CureMetrix Joins Forces with AuntMinnie.com and AuntMinnieEurope.com for Virtual Conference

Women’s Health and AI, CureMetrix Joins Forces with AuntMinnie.com and AuntMinnieEurope.com for Virtual Conference

Like many innovations that have supported better clinical and financial outcomes over the years, artificial intelligence (AI) is making an impact on radiology practices: reducing reading time, increasing cancer detection, and reducing false positives in breast cancer detection. ...

ByCureMetrix, Inc.


CureMetrix and CureMatch Align to Support President Biden’s Relaunch of Cancer Moonshot

CureMetrix and CureMatch Align to Support President Biden’s Relaunch of Cancer Moonshot

n response to President Biden’s relaunch of Cancer Moonshot and his White House commitment to end cancer as we know it, healthcare technology executives for CureMetrix and CureMatch highlighted joint innovation as core to better detection and more personalized cancer treatment. “We commend President Biden’s program to end cancer as we know it, which starts with early detection ...

ByCureMetrix, Inc.


ZetaMet™ Receives Breakthrough Device Designation from U.S. Food and Drug Administration (FDA) for Treatment of Metastatic Bone Cancers

ZetaMet™ Receives Breakthrough Device Designation from U.S. Food and Drug Administration (FDA) for Treatment of Metastatic Bone Cancers

The technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone Zetagen Therapeutics is developing the therapy for patients living with metastatic bone lesions and other osteologic conditions The Company is targeting its first human clinical trial for metastatic bone lesions to begin in early 2022 Zetagen Therapeutics, a private, ...

ByZetagen Therapeutics Inc.


VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence

VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence

VIDA Diagnostics, Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of a new AI-powered portal. The cloud-based VIDA Intelligence Portal (VIP) streamlines challenges often associated with imaging in trials such as site onboarding, staff training, image data management, and data quality. Leveraging a powerful AI engine, the portal automates cumbersome ...

ByVIDA Diagnostics Inc.


New Insights on AI for Radiology being delivered by CureMetrix at RSNA 2021 Annual Meeting

New Insights on AI for Radiology being delivered by CureMetrix at RSNA 2021 Annual Meeting

CureMetrix, Inc., a global healthcare technology company that develops AI-based software for radiology, will present multiple in-person and virtual sessions at the 2021 Radiological Society of North American (RSNA) Scientific Assembly and Annual Meeting, a hybrid event that will take place both online and live at McCormick Place in Chicago, IL, November 28 to December 2, 2021. Notably, at the ...

ByCureMetrix, Inc.


New Research Shows CureMetrix AI More Accurately Flags Anomalies in Mammograms and Improves Turnaround Time

New Research Shows CureMetrix AI More Accurately Flags Anomalies in Mammograms and Improves Turnaround Time

New research finds that artificial intelligence (AI) by CureMetrix, Inc., a global healthcare technology company that develops AI-driven software for radiology, can greatly improve turnaround time for mammogram results and more accurately flag anomalies in a mammogram. The Journal of the American College of Radiology (JACR) has published a case study documenting the two-year, in-practice clinical ...

ByCureMetrix, Inc.


New Device Taps Brain Signals To Help Stroke Patients Regain Hand Function

New Device Taps Brain Signals To Help Stroke Patients Regain Hand Function

People recovering from a stroke will soon have access to a device that can help restore a disabled hand. The Food And Drug Administration has authorized a device called IpsiHand from the uninjured side of a patient's brain to help rewire circuits controlling the hand, wrist and arm. The device can be used at home and offers stroke patients "an additional treatment option to help them ...

ByNeurolutions


Nipro Medical Corporation announces the creation of Vascular Division in the U.S.

Nipro Medical Corporation announces the creation of Vascular Division in the U.S.

Nipro Medical Corporation (NMC), a leading Renal, Medical, Surgical, and Interventional Radiology products manufacturer, announces the creation of a Vascular Division in the U.S. ...

ByInfraredx, Inc.


FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology

FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology

The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical Instruments, Inc. (Seno) premarket approval (PMA) for its groundbreaking diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company’s Imagio® Breast Imaging System ...

BySeno Medical Instruments, Inc.


MagicTouch SCB Granted ‘Breakthrough Device Designation’ for the treatment of Small Coronary Artery Lesions.

MagicTouch SCB Granted ‘Breakthrough Device Designation’ for the treatment of Small Coronary Artery Lesions.

Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for the MagicTouch SCB Sirolimus Coated Balloon Catheter, for the treatment of small coronary artery lesions in Coronary Artery Disease (CAD). The proposed indication for use includes “The ...

ByConcept Medical Inc.


AventaMed selected as Test Case for RWE by NESTcc

AventaMed selected as Test Case for RWE by NESTcc

The new Test-Cases span the medical device total product lifecycle (TPLC) and include projects that have regulatory (i.e., pre-market and postmarket pathways) and coverage applications. ...

ByAventaMed DAC


FDA approves first artificial iris

FDA approves first artificial iris

The U.S. Food and Drug Administration has announced its approval of the first stand-alone prosthetic iris in the United States that could help patients with certain types of eye damage see clearly and improve their appearance. The surgically implanted device, called the CustomFlex Artificial Iris, is meant to treat adults and children whose iris — the part of the eye that is colored around ...

ByVEO Ophthalmics, LLC


NNSA, FBI conclude radiological security exercise at NIEHS in North Carolina

The National Nuclear Security Administration (NNSA) and the Federal Bureau of Investigation (FBI) announced the completion of a table-top counterterrorism exercise at the National Institute of Environmental Health Sciences (NIEHS) in Research Triangle Park, N.C. The exercise, Environmental Thunder, was the latest in NNSA’s series of nationwide exercises aimed at giving federal, state and ...

ByNational Institute of Environmental Health Sciences (NIEHS)


FDA Proposal Responds to President Obama Order

FDA Proposal Responds to President Obama Order

The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) published on January 19, 2011, a “plan containing 25 actions it intends to implement during 2011 to improve the most common path to market for medical ...

ByBergeson & Campbell, P.C.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT